MedTrace Logo

The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM

NCT02648685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 337

Last updated 2020-02-11

No results posted yet for this study

Summary

There was no any China mainland data showing the contribution of BBG and PBG to HbA1c in T2DM patients treated with OADs using the CGM method. Therefore this study is aimed to investigate the contribution of BBG and PBG to HbA1c in Chinese T2DM patients treated with OADs using CGMS. It's expected to generate evidence to support the concept of individualized therapy when patients are uncontrolled by OADs.

Conditions

  • Diabetes, Type 2

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Xingwu Ran, Doctor · West China Hospital. Endocrinology Department.

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2019-12-28
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02648685 on ClinicalTrials.gov